Literature DB >> 34264333

Remdesivir Use and Hospital Length of Stay-The Paradox of a Clinical Trial vs Real-Life Use.

Gio J Baracco1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34264333     DOI： 10.1001/jamanetworkopen.2021.16057

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  3 in total

Review 1.  Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.

Authors:  Santiago Moreno; Bernardino Alcázar; Carlos Dueñas; Juan González Del Castillo; Julián Olalla; Antonio Antela
Journal:  Drug Des Devel Ther       Date:  2022-03-25       Impact factor: 4.162

2.  Evaluation of Antibacterial and Antiviral Drug Effectiveness in COVID-19 Therapy: A Data-Driven Retrospective Approach.

Authors:  Rika Yulia; Putri Ayu Irma Ikasanti; Fauna Herawati; Ruddy Hartono; Puri Safitri Hanum; Dewi Ramdani; Abdul Kadir Jaelani; Kevin Kantono; Heru Wijono
Journal:  Pathophysiology       Date:  2022-03-07

3.  Study of Clinical Outcome and Healthcare Modalities of COVID-19 Patients Treated With Remdesivir at a Tertiary Care Teaching Hospital.

Authors:  Tejas A Acharya; Krupal J Joshi; Divyesh D Patel; Shyam N Shah; Dimple S Mehta
Journal:  Cureus       Date:  2022-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.